1-225845227-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001136018.4(EPHX1):c.1248G>A(p.Lys416Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00759 in 1,614,102 control chromosomes in the GnomAD database, including 473 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.026 ( 144 hom., cov: 32)
Exomes 𝑓: 0.0057 ( 329 hom. )
Consequence
EPHX1
NM_001136018.4 synonymous
NM_001136018.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.44
Publications
10 publications found
Genes affected
EPHX1 (HGNC:3401): (epoxide hydrolase 1) Epoxide hydrolase is a critical biotransformation enzyme that converts epoxides from the degradation of aromatic compounds to trans-dihydrodiols which can be conjugated and excreted from the body. Epoxide hydrolase functions in both the activation and detoxification of epoxides. Mutations in this gene cause preeclampsia, epoxide hydrolase deficiency or increased epoxide hydrolase activity. Alternatively spliced transcript variants encoding the same protein have been found for this gene.[provided by RefSeq, Dec 2008]
TMEM63A (HGNC:29118): (transmembrane protein 63A) Enables mechanosensitive ion channel activity. Predicted to be involved in cation transmembrane transport. Located in centriolar satellite and lysosomal membrane. Implicated in hypomyelinating leukodystrophy. [provided by Alliance of Genome Resources, Apr 2022]
TMEM63A Gene-Disease associations (from GenCC):
- leukodystrophy, hypomyelinating, 19, transient infantileInheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 1-225845227-G-A is Benign according to our data. Variant chr1-225845227-G-A is described in ClinVar as Benign. ClinVar VariationId is 1223052.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.44 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0815 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EPHX1 | ENST00000272167.10 | c.1248G>A | p.Lys416Lys | synonymous_variant | Exon 9 of 9 | 1 | NM_001136018.4 | ENSP00000272167.5 | ||
| EPHX1 | ENST00000366837.5 | c.1248G>A | p.Lys416Lys | synonymous_variant | Exon 9 of 9 | 1 | ENSP00000355802.4 | |||
| EPHX1 | ENST00000614058.4 | c.1248G>A | p.Lys416Lys | synonymous_variant | Exon 9 of 9 | 1 | ENSP00000480004.1 | |||
| ENSG00000242861 | ENST00000424332.1 | n.43+1253C>T | intron_variant | Intron 1 of 1 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0261 AC: 3973AN: 152172Hom.: 142 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
3973
AN:
152172
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0131 AC: 3294AN: 251448 AF XY: 0.0111 show subpopulations
GnomAD2 exomes
AF:
AC:
3294
AN:
251448
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00565 AC: 8263AN: 1461812Hom.: 329 Cov.: 33 AF XY: 0.00542 AC XY: 3940AN XY: 727194 show subpopulations
GnomAD4 exome
AF:
AC:
8263
AN:
1461812
Hom.:
Cov.:
33
AF XY:
AC XY:
3940
AN XY:
727194
show subpopulations
African (AFR)
AF:
AC:
2716
AN:
33474
American (AMR)
AF:
AC:
177
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
AC:
27
AN:
26134
East Asian (EAS)
AF:
AC:
3591
AN:
39700
South Asian (SAS)
AF:
AC:
563
AN:
86252
European-Finnish (FIN)
AF:
AC:
14
AN:
53416
Middle Eastern (MID)
AF:
AC:
45
AN:
5726
European-Non Finnish (NFE)
AF:
AC:
440
AN:
1112004
Other (OTH)
AF:
AC:
690
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
558
1117
1675
2234
2792
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0262 AC: 3992AN: 152290Hom.: 144 Cov.: 32 AF XY: 0.0256 AC XY: 1904AN XY: 74466 show subpopulations
GnomAD4 genome
AF:
AC:
3992
AN:
152290
Hom.:
Cov.:
32
AF XY:
AC XY:
1904
AN XY:
74466
show subpopulations
African (AFR)
AF:
AC:
3275
AN:
41566
American (AMR)
AF:
AC:
129
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
3472
East Asian (EAS)
AF:
AC:
455
AN:
5158
South Asian (SAS)
AF:
AC:
48
AN:
4830
European-Finnish (FIN)
AF:
AC:
2
AN:
10618
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
36
AN:
68020
Other (OTH)
AF:
AC:
44
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
193
387
580
774
967
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
230
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.